| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hye-Jin Kim, Soo-Yeon Kim, Min Ho Ju, Soo Yong Lee, Gyeong-Jo Byeon, Hee Young Ki. Early extubation after left ventricular assist device implantation in a patient with Duchenne muscular dystrophy: a case report. Journal of anesthesia. vol 35. issue 3. 2021-07-08. PMID:33782774. |
respiratory failure may occur due to muscle weakness after surgery under general anesthesia in patients with dmd, and weaning from mechanical ventilation may be delayed or difficult. |
2021-07-08 |
2023-08-13 |
Not clear |
| Agnieszka Łoboda, Józef Dula. Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Pharmacological reports : PR. vol 72. issue 5. 2021-07-02. PMID:32691346. |
duchenne muscular dystrophy (dmd) is a severe x-linked neuromuscular childhood disorder that causes progressive muscle weakness and degeneration and results in functional decline, loss of ambulation and early death of young men due to cardiac or respiratory failure. |
2021-07-02 |
2023-08-13 |
human |
| Meral Bilgilisoy Filiz, Naciye Füsun Toraman, Muhammet Gültekin Kutluk, Serkan Filiz, Şebnem Koldaş Doğan, Tuncay Çakır, Aylin Yama. Effects of lumbar lordosis increment on gait deteriorations in ambulant boys with Duchenne Muscular Dystrophy: A cross-sectional study. Brazilian journal of physical therapy. 2021-06-13. PMID:34119442. |
increment of lumbar lordosis, a frequent spinal finding in duchenne muscular dystrophy (dmd), is a compensatory mechanism secondary to muscle weakness. |
2021-06-13 |
2023-08-13 |
Not clear |
| Xia Dong, Tiankun Hui, Jie Chen, Zheng Yu, Dongyan Ren, Suqi Zou, Shunqi Wang, Erkang Fei, Huifeng Jiao, Xinsheng La. Metformin Frontiers in physiology. vol 12. 2021-05-22. PMID:34012406. |
metformin duchenne muscular dystrophy (dmd) is a genetic neuromuscular disease characterized by progressive muscle weakness and wasting. |
2021-05-22 |
2023-08-13 |
mouse |
| Ryouhei Komaki, Yasumasa Hashimoto, Madoka Mori-Yoshimura, Yasushi Oya, Hotake Takizawa, Narihiro Minami, Ichizo Nishino, Yoshitsugu Aoki, Yuji Takahash. Severe cardiac involvement with preserved truncated dystrophin expression in Becker muscular dystrophy by +1G>A DMD splice-site mutation: a case report. Journal of human genetics. vol 65. issue 10. 2021-05-06. PMID:32504006. |
becker muscular dystrophy (bmd) is caused by specific mutations in the dmd gene that causes progressive muscle weakness and primarily affects skeletal and cardiac muscle. |
2021-05-06 |
2023-08-13 |
Not clear |
| Richard M Lovering, Shama R Iyer, Benjamin Edwards, Kay E Davie. Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neuroscience letters. vol 737. 2021-04-30. PMID:32818587. |
the focus of this review is on duchenne muscular dystrophy (dmd), which is caused by the absence of the protein dystrophin and is characterized as a neuromuscular disease in which muscle weakness, increased susceptibility to muscle injury, and inadequate repair appear to underlie the pathology. |
2021-04-30 |
2023-08-13 |
human |
| Luca Bello, Grazia D'Angelo, Matteo Villa, Aurora Fusto, Sara Vianello, Beatrice Merlo, Daniele Sabbatini, Andrea Barp, Sandra Gandossini, Francesca Magri, Giacomo P Comi, Marina Pedemonte, Paola Tacchetti, Valentina Lanzillotta, Federica Trucco, Adele D'Amico, Enrico Bertini, Guja Astrea, Luisa Politano, Riccardo Masson, Giovanni Baranello, Emilio Albamonte, Elisa De Mattia, Fabrizio Rao, Valeria A Sansone, Stefano Previtali, Sonia Messina, Gian Luca Vita, Angela Berardinelli, Tiziana Mongini, Antonella Pini, Marika Pane, Eugenio Mercuri, Andrea Vianello, Claudio Bruno, Eric P Hoffman, Lauren Morgenroth, Heather Gordish-Dressman, Craig M McDonald, Elena Pegorar. Genetic modifiers of respiratory function in Duchenne muscular dystrophy. Annals of clinical and translational neurology. vol 7. issue 5. 2021-04-19. PMID:32343055. |
furthermore, we analyzed pft associations with different dmd mutation types, and with genetic variants in spp1, ltbp4, cd40, and actn3, known to modify skeletal muscle weakness in dmd. |
2021-04-19 |
2023-08-13 |
Not clear |
| Layana Marques, Guilherme Augusto de Freitas Fregonezi, Ilsa Priscila Santos, Ana Aline Marcelino, Jéssica Danielle Medeiros da Fonsêca, Mario Emílio Teixeira Dourado-Júnior, Andrea Aliverti, Antonio Sarmento, Vanessa Regiane Resquet. Effects of Positioning on Cough Peak Flow and Muscular Electromyographic Activation in Duchenne Muscular Dystrophy. Respiratory care. vol 65. issue 11. 2021-02-25. PMID:32546537. |
advanced stages of duchenne muscular dystrophy (dmd) result in muscle weakness and the inability to generate an effective cough. |
2021-02-25 |
2023-08-13 |
human |
| Gang Liu, Dingyuan Ma, Jiahuang Li, Chunyu Luo, Yun Sun, Jingjing Zhang, Ping Hu, Wenwei Tang, Zhengfeng X. A novel COQ8A missense variant associated with a mild form of primary coenzyme Q10 deficiency type 4. Clinical biochemistry. vol 84. 2021-01-27. PMID:32553579. |
the objective of this study was to investigate the genetic cause of muscle weakness in a proband who had a negative dmd gene test for becker muscular dystrophy. |
2021-01-27 |
2023-08-13 |
Not clear |
| Justin S Dhindsa, Angela L McCall, Laura M Strickland, Anna F Fusco, Amanda F Kahn, Mai K ElMalla. Motor axonopathies in a mouse model of Duchenne muscular dystrophy. Scientific reports. vol 10. issue 1. 2021-01-21. PMID:32488044. |
skeletal muscle weakness and eventual muscle degradation due to loss of dystrophin are well-documented pathological hallmarks of dmd. |
2021-01-21 |
2023-08-13 |
mouse |
| Emma Koenig, Bhajan Singh, Jamie Woo. Mechanical insufflation-exsufflation for an individual with Duchenne muscular dystrophy and a lower respiratory infection. Respirology case reports. vol 5. issue 2. 2021-01-09. PMID:27999675. |
duchenne muscular dystrophy (dmd) is an x-linked recessive myopathy associated with progressive muscle weakness and wasting, loss of ambulation, respiratory insufficiency, weak cough, repeated respiratory infections, and ultimately death from respiratory failure in early adulthood. |
2021-01-09 |
2023-08-13 |
Not clear |
| Karima Relizani, Graziella Griffith, Lucía Echevarría, Faouzi Zarrouki, Patricia Facchinetti, Cyrille Vaillend, Christian Leumann, Luis Garcia, Aurélie Goyenvall. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model. Molecular therapy. Nucleic acids. vol 8. 2021-01-09. PMID:28918017. |
a novel class of aons made of tricyclo-dna (tcdna) is considered very promising for the treatment of duchenne muscular dystrophy (dmd), a neuromuscular disease typically caused by frameshifting deletions or nonsense mutations in the gene-encoding dystrophin and characterized by progressive muscle weakness, cardiomyopathy, and respiratory failure in addition to cognitive impairment. |
2021-01-09 |
2023-08-13 |
mouse |
| Claudia R Senesac, Alison M Barnard, Donovan J Lott, Kavya S Nair, Ann T Harrington, Rebecca J Willcocks, Kirsten L Zilke, William D Rooney, Glenn A Walter, Krista Vandenborn. Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic. Physical therapy. vol 100. issue 11. 2020-12-24. PMID:32737968. |
duchenne muscular dystrophy (dmd) is a muscle degenerative disorder that manifests in early childhood and results in progressive muscle weakness. |
2020-12-24 |
2023-08-13 |
Not clear |
| Jingyun Guan, Xinnong Liu, Haiyan Zhang, Xiaomeng Yang, Yanyan Ma, Yue Li, Zhongtao Gai, Yi Li. Reprogramming of human Peripheral Blood Mononuclear Cell (PBMC) from a Chinese patient suffering Duchenne muscular dystrophy to iPSC line (SDQLCHi007-A) carrying deletion of 49-50 exons in the DMD gene. Stem cell research. vol 42. 2020-12-04. PMID:31812072. |
duchenne muscular dystrophy (dmd), an x-linked genetic disorder characterized by progressive muscle weakness and atrophies affecting skeletal and cardiac muscles, is caused by mutations in dystrophin (dmd) gene that spans 79 exons. |
2020-12-04 |
2023-08-13 |
human |
| Lee-Jae Guo, Jonathan H Soslow, Amanda K Bettis, Peter P Nghiem, Kevin J Cummings, Mark W Lenox, Matthew W Miller, Joe N Kornegay, Christopher F Spurne. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy. Journal of the American Heart Association. vol 8. issue 16. 2020-11-10. PMID:31411085. |
background duchenne muscular dystrophy (dmd) is an x-linked disease that causes progressive muscle weakness. |
2020-11-10 |
2023-08-13 |
Not clear |
| Ines Vandekerckhove, Nathalie De Beukelaer, Marleen Van den Hauwe, Benjamin R Shuman, Katherine M Steele, Anja Van Campenhout, Nathalie Goemans, Kaat Desloovere, Marije Goudriaa. Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophy. PloS one. vol 15. issue 9. 2020-10-26. PMID:32877421. |
our aim was to determine if synergy weights and activations are altered in duchenne muscular dystrophy (dmd) and if these alterations could be linked to muscle weakness. |
2020-10-26 |
2023-08-13 |
Not clear |
| X Zikou, G Papathanakos, E Dounousi, G Nakos, V Kouloura. Hypokalemia-induced cardiac arrest in a Duchenne muscular dystrophy patient. Hippokratia. vol 20. issue 2. 2020-10-01. PMID:28416915. |
duchenne muscular dystrophy (dmd) is a progressive myopathic disorder, inherited as x-linked recessive traits, in which muscle weakness is the primary symptom. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yuko Miyagoe-Suzuki, Takashi Nishiyama, Miho Nakamura, Asako Narita, Fusako Takemura, Satoru Masuda, Narihiro Minami, Kumiko Murayama, Hirofumi Komaki, Yu-Ichi Goto, Shin'ichi Taked. Induction of Pluripotent Stem Cells from a Manifesting Carrier of Duchenne Muscular Dystrophy and Characterization of Their X-Inactivation Status. Stem cells international. vol 2017. 2020-10-01. PMID:28491099. |
three to eight percent of female carriers of duchenne muscular dystrophy (dmd) develop dystrophic symptoms ranging from mild muscle weakness to a rapidly progressive dmd-like muscular dystrophy due to skewed inactivation of x chromosomes during early development. |
2020-10-01 |
2023-08-13 |
human |
| David P Burns, Izza Ali, Clement Rieux, James Healy, Greg Jasionek, Ken D O'Hallora. Tempol Supplementation Restores Diaphragm Force and Metabolic Enzyme Activities in mdx Mice. Antioxidants (Basel, Switzerland). vol 6. issue 4. 2020-10-01. PMID:29210997. |
duchenne muscular dystrophy (dmd) is characterized by striated muscle weakness, cardiomyopathy, and respiratory failure. |
2020-10-01 |
2023-08-13 |
mouse |
| Marije Goudriaan, Benjamin R Shuman, Katherine M Steele, Marleen Van den Hauwe, Nathalie Goemans, Guy Molenaers, Kaat Desloover. Non-neural Muscle Weakness Has Limited Influence on Complexity of Motor Control during Gait. Frontiers in human neuroscience. vol 12. 2020-10-01. PMID:29445330. |
cerebral palsy (cp) and duchenne muscular dystrophy (dmd) are neuromuscular disorders characterized by muscle weakness. |
2020-10-01 |
2023-08-13 |
Not clear |